Metastatic solid cancers. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Neoplastic Stem Cells Tumor Cells, Cultured Breast Prostate HCT116 Cells MCF-7 Cells HT29 Cells Lymph Nodes Cell Line Neoplastic Cells, Circulating Epithelial Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases55

Neoplasms Neoplasm Metastasis Neoplasms, Radiation-Induced Neoplasms, Second Primary Lung Neoplasms Pancreatic Neoplasms Breast Neoplasms Leukemia, Radiation-Induced Colonic Neoplasms Neoplasm Invasiveness Leukemia Ovarian Neoplasms Prostatic Neoplasms Colorectal Neoplasms Stomach Neoplasms Neutropenia Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma Disease Progression Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Neoplasm Recurrence, Local Rectal Neoplasms Cell Transformation, Neoplastic Endometrial Neoplasms Esophageal Neoplasms Adenocarcinoma Liver Neoplasms Head and Neck Neoplasms Neovascularization, Pathologic Bone Neoplasms Carcinoma, Small Cell Mouth Neoplasms Neoplasms, Hormone-Dependent Neoplasms, Glandular and Epithelial Skin Neoplasms Genital Neoplasms, Female Gastrointestinal Neoplasms Precancerous Conditions Neoplasms, Experimental Thyroid Neoplasms Mammary Neoplasms, Experimental Kidney Neoplasms Melanoma Neoplasms, Multiple Primary Pharyngeal Neoplasms Disease Models, Animal Neoplastic Cells, Circulating Carcinoma, Lobular Testicular Neoplasms Neoplastic Syndromes, Hereditary Carcinoma, Pancreatic Ductal Breast Neoplasms, Male

Chemicals and Drugs52

Antineoplastic Agents Tumor Markers, Biological Cancer Vaccines Neoplasm Proteins Receptors, Estrogen RNA, Messenger Receptor, erbB-2 DNA, Neoplasm Prostate-Specific Antigen RNA, Small Interfering Antineoplastic Agents, Phytogenic Fluorouracil Tumor Suppressor Protein p53 Cisplatin Antigens, Neoplasm Tamoxifen Paclitaxel Receptors, Progesterone Antineoplastic Agents, Hormonal Antibodies, Monoclonal Anticarcinogenic Agents Receptor, Epidermal Growth Factor Deoxycytidine MicroRNAs Tumor Suppressor Proteins Antimetabolites, Antineoplastic Taxoids DNA-Binding Proteins RNA, Neoplasm Antibodies, Monoclonal, Humanized Receptors, Androgen Protein Kinase Inhibitors Transcription Factors Proto-Oncogene Proteins BRCA2 Protein Quinazolines Nuclear Proteins Androgens Carcinogens Proto-Oncogene Proteins c-akt BRCA1 Protein Estrogens Solid Waste Camptothecin Antibiotics, Antineoplastic Organoplatinum Compounds Carcinoembryonic Antigen Estrogen Receptor alpha Enzyme Inhibitors Androgen Antagonists Protein-Serine-Threonine Kinases DNA Primers

Analytical, Diagnostic and Therapeutic Techniques and Equipment76

Maximum Tolerated Dose Drug Administration Schedule Treatment Outcome Early Detection of Cancer Radiometry Risk Dose-Response Relationship, Radiation Xenograft Model Antitumor Assays Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Neoplasm Transplantation Follow-Up Studies Radiotherapy Risk Factors Cohort Studies Radiation Dosage Prognosis Whole-Body Irradiation Incidence Survival Analysis Survival Rate Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Prospective Studies Registries Neoplasm Staging Risk Assessment Combined Modality Therapy Disease-Free Survival Blotting, Western Transplantation, Heterologous Odds Ratio Sensitivity and Specificity Chemotherapy, Adjuvant Transplantation, Homologous Drug Screening Assays, Antitumor Hematopoietic Stem Cell Transplantation Tumor Burden Oligonucleotide Array Sequence Analysis Multivariate Analysis Kaplan-Meier Estimate Mammography Clinical Trials as Topic Molecular Targeted Therapy Polymerase Chain Reaction Transplantation Conditioning Questionnaires Reproducibility of Results SEER Program Models, Biological Predictive Value of Tests Transfection Case-Control Studies Logistic Models Neoplasm Grading Neoplasms, Experimental Tissue Array Analysis Confidence Intervals Flow Cytometry Mammary Neoplasms, Experimental Immunoenzyme Techniques Drug Delivery Systems Gene Knockdown Techniques Biopsy Immunohistochemistry Palliative Care Mastectomy Tomography, X-Ray Computed DNA Mutational Analysis Radiotherapy, Adjuvant Disease Models, Animal Genetic Testing Immunotherapy Genetic Therapy Prostatectomy Colonoscopy

Psychiatry and Psychology1

Phenomena and Processes46

Maximum Tolerated Dose Dose-Response Relationship, Drug Risk Dose-Response Relationship, Radiation Gene Expression Regulation, Neoplastic Radiation Dosage Cell Proliferation Apoptosis Time Factors Drug Resistance, Neoplasm Genetic Predisposition to Disease Signal Transduction Mutation Cell Survival Odds Ratio Sensitivity and Specificity DNA Methylation Cell Movement Genotype Cell Division Down-Regulation Genes, BRCA1 Polymorphism, Genetic Cell Growth Processes Promoter Regions, Genetic Cell Cycle Transfection RNA Interference Up-Regulation Gene Silencing Genes, Tumor Suppressor Genes, Neoplasm Base Sequence Germ-Line Mutation Genes, p53 Diet Phenotype Gene Expression Postmenopause Genes, BRCA2 Phosphorylation Drug Synergism Tumor Microenvironment Epithelial-Mesenchymal Transition Alleles Epigenesis, Genetic

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena4

Nuclear Warfare National Cancer Institute (U.S.)Quality of Life Age Distribution

Technology, Industry, Agriculture1

Nuclear Weapons

Humanities1

Quality of Life

Information Science7

Incidence Survival Rate Registries Questionnaires SEER Program Molecular Sequence Data Base Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care36

Treatment Outcome Risk Dose-Response Relationship, Radiation Retrospective Studies Follow-Up Studies Risk Factors Cohort Studies Radiation Dosage Incidence Age Factors Occupational Exposure Survival Analysis Survival Rate National Cancer Institute (U.S.)Prospective Studies Registries Risk Assessment Disease-Free Survival Odds Ratio Sensitivity and Specificity Multivariate Analysis Kaplan-Meier Estimate Clinical Trials as Topic Questionnaires Reproducibility of Results SEER Program Predictive Value of Tests Case-Control Studies American Cancer Society Logistic Models Confidence Intervals Palliative Care Solid Waste Genetic Testing Age Distribution Refuse Disposal

Geographicals5

Russia United States Japan China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Neoplasms Neoplasm Metastasis Maximum Tolerated Dose Dose-Response Relationship, Drug Antineoplastic Agents Drug Administration Schedule Neoplasms, Radiation-Induced Treatment Outcome Nuclear Weapons Neoplasms, Second Primary Cell Line, Tumor Nuclear Warfare Early Detection of Cancer Lung Neoplasms Pancreatic Neoplasms Mice, Nude Radiometry Breast Neoplasms Leukemia, Radiation-Induced Colonic Neoplasms Risk Russia Dose-Response Relationship, Radiation Neoplasm Invasiveness Gene Expression Regulation, Neoplastic Xenograft Model Antitumor Assays Survivors Retrospective Studies Leukemia Antineoplastic Combined Chemotherapy Protocols Ovarian Neoplasms Neoplasm Transplantation Prostatic Neoplasms Follow-Up Studies Radiotherapy Risk Factors Cohort Studies Tumor Markers, Biological Neoplastic Stem Cells Colorectal Neoplasms Radiation Dosage Stomach Neoplasms Prognosis Whole-Body Irradiation Incidence Cell Proliferation Age Factors Neutropenia Apoptosis Tumor Cells, Cultured Cancer Vaccines Neoplasm Proteins Occupational Exposure Survival Analysis Uterine Cervical Neoplasms Time Factors Survival Rate Drug Resistance, Neoplasm Genetic Predisposition to Disease Carcinoma Disease Progression Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Reverse Transcriptase Polymerase Chain Reaction National Cancer Institute (U.S.)Gene Expression Profiling Signal Transduction Prospective Studies Mutation Registries Receptors, Estrogen Neoplasm Staging RNA, Messenger Receptor, erbB-2 Risk Assessment United States Neoplasm Recurrence, Local Combined Modality Therapy Rectal Neoplasms DNA, Neoplasm Disease-Free Survival Blotting, Western Cell Transformation, Neoplastic Transplantation, Heterologous Prostate-Specific Antigen RNA, Small Interfering Antineoplastic Agents, Phytogenic Endometrial Neoplasms Cell Survival Odds Ratio Sensitivity and Specificity DNA Methylation Fluorouracil Chemotherapy, Adjuvant Tumor Suppressor Protein p53 Smoking Transplantation, Homologous Cisplatin Esophageal Neoplasms

No FAQ available that match "metastatic solid cancers"